nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—CYP19A1—gestational diabetes	0.874	1	CbGaD
Betamethasone—ABCB1—Glyburide—gestational diabetes	0.0428	0.625	CbGbCtD
Betamethasone—CYP3A4—Glyburide—gestational diabetes	0.0256	0.375	CbGbCtD
Betamethasone—PLA2G1B—islet of Langerhans—gestational diabetes	0.00363	0.14	CbGeAlD
Betamethasone—PTGS2—Nicotinamide salvaging—NAMPT—gestational diabetes	0.00244	0.13	CbGpPWpGaD
Betamethasone—PLA2G1B—head—gestational diabetes	0.00178	0.0684	CbGeAlD
Betamethasone—Testolactone—CYP19A1—gestational diabetes	0.00158	0.273	CrCbGaD
Betamethasone—PTGS2—Nicotinate metabolism—NAMPT—gestational diabetes	0.0013	0.0691	CbGpPWpGaD
Betamethasone—NR3C2—uterus—gestational diabetes	0.00117	0.0451	CbGeAlD
Betamethasone—Fludrocortisone—AR—gestational diabetes	0.00115	0.199	CrCbGaD
Betamethasone—NR3C2—adipose tissue—gestational diabetes	0.00115	0.0441	CbGeAlD
Betamethasone—PGR—uterus—gestational diabetes	0.00109	0.0419	CbGeAlD
Betamethasone—Fluoxymesterone—SHBG—gestational diabetes	0.00109	0.187	CrCbGaD
Betamethasone—PGR—adipose tissue—gestational diabetes	0.00107	0.041	CbGeAlD
Betamethasone—NR3C2—Nuclear Receptor transcription pathway—AR—gestational diabetes	0.00101	0.0537	CbGpPWpGaD
Betamethasone—CYP19A1—uterus—gestational diabetes	0.000982	0.0377	CbGeAlD
Betamethasone—NR3C1—islet of Langerhans—gestational diabetes	0.000966	0.0371	CbGeAlD
Betamethasone—CYP19A1—adipose tissue—gestational diabetes	0.00096	0.0369	CbGeAlD
Betamethasone—NR3C2—vagina—gestational diabetes	0.000954	0.0367	CbGeAlD
Betamethasone—Fluoxymesterone—AR—gestational diabetes	0.000954	0.164	CrCbGaD
Betamethasone—NR3C1—embryo—gestational diabetes	0.000934	0.0359	CbGeAlD
Betamethasone—PGR—Ovarian Infertility Genes—CYP19A1—gestational diabetes	0.000916	0.0488	CbGpPWpGaD
Betamethasone—PGR—vagina—gestational diabetes	0.000887	0.0341	CbGeAlD
Betamethasone—NR3C2—head—gestational diabetes	0.000882	0.0339	CbGeAlD
Betamethasone—PTGS2—islet of Langerhans—gestational diabetes	0.000836	0.0321	CbGeAlD
Betamethasone—Blindness—Glyburide—gestational diabetes	0.000825	0.121	CcSEcCtD
Betamethasone—PGR—head—gestational diabetes	0.000819	0.0315	CbGeAlD
Betamethasone—PTGS2—embryo—gestational diabetes	0.000808	0.031	CbGeAlD
Betamethasone—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—gestational diabetes	0.000805	0.0429	CbGpPWpGaD
Betamethasone—PGR—Nuclear Receptors—AR—gestational diabetes	0.000777	0.0414	CbGpPWpGaD
Betamethasone—CYP19A1—head—gestational diabetes	0.000737	0.0283	CbGeAlD
Betamethasone—Hydrocortisone—SHBG—gestational diabetes	0.000661	0.114	CrCbGaD
Betamethasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NAMPT—gestational diabetes	0.000649	0.0345	CbGpPWpGaD
Betamethasone—NR3C1—uterus—gestational diabetes	0.00063	0.0242	CbGeAlD
Betamethasone—NR3C1—adipose tissue—gestational diabetes	0.000616	0.0237	CbGeAlD
Betamethasone—PGR—Nuclear Receptor transcription pathway—AR—gestational diabetes	0.000614	0.0327	CbGpPWpGaD
Betamethasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—GCK—gestational diabetes	0.000562	0.0299	CbGpPWpGaD
Betamethasone—PTGS2—uterus—gestational diabetes	0.000545	0.0209	CbGeAlD
Betamethasone—PTGS2—adipose tissue—gestational diabetes	0.000533	0.0205	CbGeAlD
Betamethasone—ABCB1—islet of Langerhans—gestational diabetes	0.000517	0.0199	CbGeAlD
Betamethasone—NR3C1—vagina—gestational diabetes	0.000512	0.0197	CbGeAlD
Betamethasone—NR3C1—Transcription factor regulation in adipogenesis—LEP—gestational diabetes	0.0005	0.0266	CbGpPWpGaD
Betamethasone—ABCB1—embryo—gestational diabetes	0.0005	0.0192	CbGeAlD
Betamethasone—NR3C1—Adipogenesis—RETN—gestational diabetes	0.000496	0.0264	CbGpPWpGaD
Betamethasone—NR3C1—head—gestational diabetes	0.000473	0.0182	CbGeAlD
Betamethasone—NR3C1—Circadian Clock—NAMPT—gestational diabetes	0.000473	0.0252	CbGpPWpGaD
Betamethasone—Vasculitis—Glyburide—gestational diabetes	0.000468	0.0684	CcSEcCtD
Betamethasone—CYP19A1—Biological oxidations—GGCT—gestational diabetes	0.00045	0.0239	CbGpPWpGaD
Betamethasone—NR3C1—Nuclear Receptors—AR—gestational diabetes	0.000449	0.0239	CbGpPWpGaD
Betamethasone—PTGS2—vagina—gestational diabetes	0.000443	0.017	CbGeAlD
Betamethasone—PTGS2—head—gestational diabetes	0.000409	0.0157	CbGeAlD
Betamethasone—PGR—Cellular roles of Anthrax toxin—TNF—gestational diabetes	0.0004	0.0213	CbGpPWpGaD
Betamethasone—Dexamethasone—CYP19A1—gestational diabetes	0.000362	0.0623	CrCbGaD
Betamethasone—NR3C1—Nuclear Receptor transcription pathway—AR—gestational diabetes	0.000355	0.0189	CbGpPWpGaD
Betamethasone—Visual disturbance—Glyburide—gestational diabetes	0.00035	0.0512	CcSEcCtD
Betamethasone—Dermatitis bullous—Glyburide—gestational diabetes	0.000347	0.0507	CcSEcCtD
Betamethasone—NR3C1—Regulation of Androgen receptor activity—AR—gestational diabetes	0.000344	0.0183	CbGpPWpGaD
Betamethasone—ABCB1—uterus—gestational diabetes	0.000337	0.0129	CbGeAlD
Betamethasone—ABCB1—adipose tissue—gestational diabetes	0.00033	0.0127	CbGeAlD
Betamethasone—Sweating increased—Glyburide—gestational diabetes	0.000279	0.0408	CcSEcCtD
Betamethasone—ABCB1—vagina—gestational diabetes	0.000274	0.0105	CbGeAlD
Betamethasone—ABCB1—head—gestational diabetes	0.000253	0.00972	CbGeAlD
Betamethasone—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—NAMPT—gestational diabetes	0.000248	0.0132	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—gestational diabetes	0.000245	0.013	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—NAMPT—gestational diabetes	0.000238	0.0126	CbGpPWpGaD
Betamethasone—NR3C1—Transcription factor regulation in adipogenesis—TNF—gestational diabetes	0.000231	0.0123	CbGpPWpGaD
Betamethasone—Visual impairment—Glyburide—gestational diabetes	0.000221	0.0323	CcSEcCtD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—GCK—gestational diabetes	0.000218	0.0116	CbGpPWpGaD
Betamethasone—Eye disorder—Glyburide—gestational diabetes	0.000214	0.0313	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—GGCT—gestational diabetes	0.000211	0.0112	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—GCK—gestational diabetes	0.000204	0.0109	CbGpPWpGaD
Betamethasone—Alopecia—Glyburide—gestational diabetes	0.000203	0.0296	CcSEcCtD
Betamethasone—Erythema—Glyburide—gestational diabetes	0.0002	0.0292	CcSEcCtD
Betamethasone—PTGS2—Overview of nanoparticle effects—TNF—gestational diabetes	0.000197	0.0105	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—ADIPOQ—gestational diabetes	0.000194	0.0103	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—GLS2—gestational diabetes	0.000184	0.0098	CbGpPWpGaD
Betamethasone—Angioedema—Glyburide—gestational diabetes	0.000182	0.0267	CcSEcCtD
Betamethasone—NR3C2—Generic Transcription Pathway—AR—gestational diabetes	0.000174	0.00927	CbGpPWpGaD
Betamethasone—Convulsion—Glyburide—gestational diabetes	0.000173	0.0253	CcSEcCtD
Betamethasone—Myalgia—Glyburide—gestational diabetes	0.00017	0.0249	CcSEcCtD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—AR—gestational diabetes	0.000169	0.00899	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000165	0.00876	CbGpPWpGaD
Betamethasone—Oedema—Glyburide—gestational diabetes	0.000163	0.0238	CcSEcCtD
Betamethasone—Shock—Glyburide—gestational diabetes	0.00016	0.0234	CcSEcCtD
Betamethasone—Nervous system disorder—Glyburide—gestational diabetes	0.00016	0.0234	CcSEcCtD
Betamethasone—Thrombocytopenia—Glyburide—gestational diabetes	0.00016	0.0233	CcSEcCtD
Betamethasone—Hyperhidrosis—Glyburide—gestational diabetes	0.000158	0.023	CcSEcCtD
Betamethasone—Anorexia—Glyburide—gestational diabetes	0.000155	0.0227	CcSEcCtD
Betamethasone—Hypotension—Glyburide—gestational diabetes	0.000152	0.0223	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.000148	0.0217	CcSEcCtD
Betamethasone—Paraesthesia—Glyburide—gestational diabetes	0.000146	0.0214	CcSEcCtD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—AR—gestational diabetes	0.000145	0.00772	CbGpPWpGaD
Betamethasone—Dyspepsia—Glyburide—gestational diabetes	0.000143	0.021	CcSEcCtD
Betamethasone—Decreased appetite—Glyburide—gestational diabetes	0.000142	0.0207	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Glyburide—gestational diabetes	0.000141	0.0206	CcSEcCtD
Betamethasone—PGR—Signaling by ERBB4—FGF2—gestational diabetes	0.00014	0.00745	CbGpPWpGaD
Betamethasone—Feeling abnormal—Glyburide—gestational diabetes	0.000134	0.0196	CcSEcCtD
Betamethasone—Gastrointestinal pain—Glyburide—gestational diabetes	0.000133	0.0195	CcSEcCtD
Betamethasone—CYP3A4—Biological oxidations—GGCT—gestational diabetes	0.000131	0.00698	CbGpPWpGaD
Betamethasone—CYP3A4—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000131	0.00698	CbGpPWpGaD
Betamethasone—Urticaria—Glyburide—gestational diabetes	0.000129	0.0189	CcSEcCtD
Betamethasone—Abdominal pain—Glyburide—gestational diabetes	0.000129	0.0188	CcSEcCtD
Betamethasone—NR3C1—Adipogenesis—LEP—gestational diabetes	0.000121	0.00643	CbGpPWpGaD
Betamethasone—Asthenia—Glyburide—gestational diabetes	0.000117	0.0171	CcSEcCtD
Betamethasone—Pruritus—Glyburide—gestational diabetes	0.000115	0.0169	CcSEcCtD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—LEP—gestational diabetes	0.000112	0.00594	CbGpPWpGaD
Betamethasone—Diarrhoea—Glyburide—gestational diabetes	0.000112	0.0163	CcSEcCtD
Betamethasone—PGR—Generic Transcription Pathway—AR—gestational diabetes	0.000106	0.00564	CbGpPWpGaD
Betamethasone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000106	0.00564	CbGpPWpGaD
Betamethasone—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000105	0.00557	CbGpPWpGaD
Betamethasone—Vomiting—Glyburide—gestational diabetes	0.000104	0.0152	CcSEcCtD
Betamethasone—Rash—Glyburide—gestational diabetes	0.000103	0.015	CcSEcCtD
Betamethasone—Dermatitis—Glyburide—gestational diabetes	0.000103	0.015	CcSEcCtD
Betamethasone—Headache—Glyburide—gestational diabetes	0.000102	0.0149	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—NAMPT—gestational diabetes	0.000101	0.00537	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—GCK—gestational diabetes	0.0001	0.00533	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—LEP—gestational diabetes	9.89e-05	0.00526	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	9.72e-05	0.00517	CbGpPWpGaD
Betamethasone—Nausea—Glyburide—gestational diabetes	9.68e-05	0.0142	CcSEcCtD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	9.35e-05	0.00498	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—gestational diabetes	9.09e-05	0.00484	CbGpPWpGaD
Betamethasone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	8.6e-05	0.00458	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—AR—gestational diabetes	8.38e-05	0.00446	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GGCT—gestational diabetes	7.69e-05	0.00409	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—CYP19A1—gestational diabetes	7.33e-05	0.0039	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—LEPR—gestational diabetes	6.8e-05	0.00362	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GLS2—gestational diabetes	6.72e-05	0.00358	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	6.63e-05	0.00353	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—AR—gestational diabetes	6.13e-05	0.00326	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—TNF—gestational diabetes	5.78e-05	0.00308	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—TNF—gestational diabetes	5.58e-05	0.00297	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MTNR1B—gestational diabetes	5.37e-05	0.00286	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—RBP4—gestational diabetes	5.24e-05	0.00279	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GGCT—gestational diabetes	5.14e-05	0.00273	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	5.11e-05	0.00272	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—AR—gestational diabetes	5.11e-05	0.00272	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—TNF—gestational diabetes	4.83e-05	0.00257	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TNF—gestational diabetes	4.57e-05	0.00243	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	4.57e-05	0.00243	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	4.5e-05	0.0024	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GLS2—gestational diabetes	4.49e-05	0.00239	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—TNF—gestational diabetes	4.47e-05	0.00238	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	4.01e-05	0.00214	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—GCK—gestational diabetes	3.7e-05	0.00197	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—NAMPT—gestational diabetes	3.68e-05	0.00196	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GCK—gestational diabetes	3.66e-05	0.00195	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GGCT—gestational diabetes	3.64e-05	0.00194	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	3.62e-05	0.00193	CbGpPWpGaD
Betamethasone—PTGS2—Disease—RBP4—gestational diabetes	3.28e-05	0.00174	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GLS2—gestational diabetes	3.18e-05	0.00169	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	3.11e-05	0.00166	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—AR—gestational diabetes	2.95e-05	0.00157	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NAMPT—gestational diabetes	2.94e-05	0.00156	CbGpPWpGaD
Betamethasone—PTGS2—Disease—GCK—gestational diabetes	2.92e-05	0.00155	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—NAMPT—gestational diabetes	2.46e-05	0.00131	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GCK—gestational diabetes	2.45e-05	0.0013	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—LEP—gestational diabetes	2.39e-05	0.00127	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GGCT—gestational diabetes	2.24e-05	0.00119	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	2.21e-05	0.00117	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GLS2—gestational diabetes	1.96e-05	0.00104	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—FGF2—gestational diabetes	1.81e-05	0.000965	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP19A1—gestational diabetes	1.79e-05	0.000952	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NAMPT—gestational diabetes	1.74e-05	0.000928	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GCK—gestational diabetes	1.73e-05	0.000923	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP19A1—gestational diabetes	1.27e-05	0.000675	CbGpPWpGaD
Betamethasone—PTGS2—Disease—FGF2—gestational diabetes	1.13e-05	0.000604	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NAMPT—gestational diabetes	1.07e-05	0.000572	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GCK—gestational diabetes	1.07e-05	0.000568	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP19A1—gestational diabetes	7.81e-06	0.000416	CbGpPWpGaD
